The frequency and absolute numbers of mItgb1-specific CD4+ tumour-infiltrating lymphocytes (TILs) from HDVax-treated or LDVax-treated mice were similar (Extended Data Fig. 1a,b). This evidence concerns the gene CD4 and neoplasm.